PREP and Parkinson disease: Taken together, although aSyn forms aggregates in the absence of PREP, our findings showed that PREP is important for aSyn-mediated toxicity and this further emphasizes the possibilities of PREP inhibitors as disease-modifying drugs for PD and other synucleinopathies.